Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Up – Time to Buy?

Eurofins Scient (OTCMKTS:ERFSFGet Free Report)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $69.19, but opened at $73.88. Eurofins Scient shares last traded at $72.34, with a volume of 635 shares trading hands.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ERFSF. Citigroup reissued a “neutral” rating on shares of Eurofins Scient in a report on Monday, February 2nd. BNP Paribas Exane upgraded Eurofins Scient to an “outperform” rating in a research note on Monday, January 5th. One equities research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold”.

Get Our Latest Report on Eurofins Scient

Eurofins Scient Stock Up 0.7%

The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77. The firm’s 50-day simple moving average is $79.36 and its 200 day simple moving average is $74.62.

About Eurofins Scient

(Get Free Report)

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.

See Also

Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.